Abstract
There are an estimated 25,000 patients who develop small cell lung cancer per year in the United States. The currently available therapy is inadequate because >95% of patients die from their small cell lung cancer [(1][1] [, 2)][2] . The work with conventional chemotherapy has not dramatically
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical cancer research : an official journal of the American Association for Cancer Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
